Skip to content

Clinical trials

Phase 2 Urologic Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urologic Diseases Phase: Phase 2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20141
20153
20191
20201
20211
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allena Pharmaceuticals3
AbbVie1
Goldfinch Bio, Inc.1
HI-Bio, A Biogen Company1
Jade Biosciences, Inc.1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
NiKang Therapeutics, Inc.1
Novartis Pharmaceuticals1
Novo Nordisk A/S1
The Methodist Hospital Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urologic Diseases13
Kidney Diseases10
Glomerulonephritis, IGA4
Glomerulonephritis3
Hyperoxaluria3
Kidney Calculi3
Nephrolithiasis3
Diabetes Complications2
Diabetes Mellitus2
Diabetic Nephropathies2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.